Stearoyl lysophosphatidylcholine inhibits endotoxin-induced caspase-11 activation

Wenbo Li, Wei Zhang, Meihong Deng, Patricia Loughran, Yiting Tang, Hong Liao, Xianying Zhang, Jian Liu, Timothy R. Billiar, Ben Lu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Stearoyl lysophosphatidylcholine (LPC) exerts protective effect during endotoxemia and in experimental sepsis, but the underlying mechanism is unclear. Here, we demonstrated that stearoyl LPC could block caspase-11-mediated macrophage pyroptosis. In vitro, stearoyl LPC significantly decreased caspase-11 activation and pyroptosis induced by lipopolysaccharide (LPS) plus cholera toxin subunit B independent of the receptor G2A. Stearoyl LPC did not affect LPS uptake by mouse peritoneal macrophages but did significantly inhibit the interaction between LPS and caspase-11. Moreover, stearoyl LPC treatment conferred significant protection against lethal endotoxemia and significantly reduced the release of IL-1a and IL-1β. These findings identify stearoyl LPC as an inhibitor of LPS-mediated caspase-11 activation. This mechanism could explain the protective action of stearoyl LPC in experimental sepsis and endotoxemia.

Original languageEnglish
Pages (from-to)339-345
Number of pages7
Issue number3
StatePublished - 2018
Externally publishedYes


  • Endotoxemia
  • Innate immunity
  • Non-canonical inflammasome
  • Pyroptosis


Dive into the research topics of 'Stearoyl lysophosphatidylcholine inhibits endotoxin-induced caspase-11 activation'. Together they form a unique fingerprint.

Cite this